Ratings by B.Riley (Yuan Zhi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/25/2026 | Whitehawk Therapeutics | WHWK | New Coverage | Buy (N/A) |
4.39 (4.19) |
-4.56% | Details | |
| 6/9/2026 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2026 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2026 | RadNet | RDNT | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2026 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | Strata Critical Medical, Inc. | SRTA | New Coverage | Buy (N/A) |
4.33 (5.41) |
24.94% | Details | |
| 3/19/2026 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2026 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2026 | The Oncology Insititute Inc. | TOI | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Radiopharm Theranostics | RADX | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2025 | RadNet | RDNT | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2025 | Radiopharm Theranostics | RADX | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2025 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | Mirion Technologies | MIR | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | Mirion Technologies | MIR | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | RadNet | RDNT | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2025 | Mirion Technologies | MIR | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2025 | The Oncology Insititute Inc. | TOI | New Coverage | Buy (N/A) |
3.21 (5.28) |
64.49% | Details | |
| 6/23/2025 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2025 | RadNet | RDNT | New Coverage | Buy (N/A) |
57.87 (68.75) |
18.8% | Details | |
| 5/14/2025 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2025 | Mirion Technologies | MIR | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2025 | Radiopharm Theranostics | RADX | New Coverage | Buy (N/A) |
6.15 (4.37) |
-28.94% | Details | |
| 12/5/2024 | Mirion Technologies | MIR | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2024 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2024 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2024 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Landsea Homes Corp. | LSEA | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2024 | CytoSorbents | CTSO | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2024 | Mirion Technologies | MIR | New Coverage | Buy (N/A) |
10.51 (17.38) |
65.37% | Details | |
| 8/14/2024 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2024 | Actinium Pharma | ATNM | Downgrade | Neutral (Buy) |
2.87 (0.98) |
-65.85% | Details | |
| 7/31/2024 | CryoPort | CYRX | Upgrade | Buy (Neutral) |
9.07 (15.49) |
70.78% | Details | |
| 7/19/2024 | Augmedix Inc. | AUGX | Downgrade | Neutral (Buy) |
0.92 (2.35) |
155.43% | Details | |
| 5/14/2024 | Augmedix Inc. | AUGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2024 | CryoPort | CYRX | Downgrade | Neutral (Buy) |
16.81 (9.07) |
-46.04% | Details | |
| 4/9/2024 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2024 | Augmedix Inc. | AUGX | New Coverage | Buy (N/A) |
4.02 (2.35) |
-41.54% | Details | |
| 3/20/2024 | Fusion Pharmaceuticals | FUSN | Downgrade | Neutral (Buy) |
21.18 (21.55) |
1.75% | Details | |
| 3/18/2024 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2024 | Landsea Homes Corp. | LSEA | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | NGM Biopharmaceuticals | NGM | Downgrade | Neutral (Buy) |
1.63 (1.54) |
-5.52% | Details | |
| 2/1/2024 | Azenta, Inc. | AZTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2024 | Perspective Therapeutics Inc | CATX | New Coverage | Buy (N/A) |
0.49 (3.63) |
640.82% | Details | |
| 1/25/2024 | Landsea Homes Corp. | LSEA | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | Ambrx Biopharma | AMAM | Downgrade | Neutral (Buy) |
13.63 (28.00) |
105.43% | Details | |
| 12/11/2023 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2023 | Tango Therapeutics Inc. | TNGX | New Coverage | Buy (N/A) |
8.35 (29.46) |
252.81% | Details | |
| 11/22/2023 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Landsea Homes Corp. | LSEA | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2023 | CytoSorbents | CTSO | New Coverage | Buy (N/A) |
2.42 (0.39) |
-83.88% | Details | |
| 7/13/2023 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2023 | Ambrx Biopharma | AMAM | New Coverage | Buy (N/A) |
14.51 (28.00) |
92.97% | Details | |
| 3/30/2023 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2023 | Iveric Bio | ISEE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2023 | Azenta, Inc. | AZTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2023 | Landsea Homes Corp. | LSEA | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2022 | Fusion Pharmaceuticals | FUSN | New Coverage | Buy (N/A) |
2.16 (21.55) |
897.69% | Details | |
| 11/16/2022 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Iveric Bio | ISEE | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2022 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2022 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2022 | Landsea Homes Corp. | LSEA | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2022 | Iveric Bio | ISEE | Upgrade | Neutral (Sell) |
20.84 (39.95) |
91.7% | Details | |
| 10/7/2022 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2022 | Iveric Bio | ISEE | Downgrade | Sell (Neutral) |
9.44 (20.84) |
120.76% | Details | |
| 8/25/2022 | Actinium Pharma | ATNM | New Coverage | Buy (N/A) |
5.91 (0.98) |
-83.42% | Details | |
| 8/15/2022 | Azenta, Inc. | AZTA | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2022 | BioVie Inc. | BIVI | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Azenta, Inc. | AZTA | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Iveric Bio | ISEE | New Coverage | Neutral (N/A) |
10.61 (9.44) |
-11.03% | Details | |
| 5/5/2022 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2022 | Azenta, Inc. | AZTA | New Coverage | Buy (N/A) |
85.96 (25.84) |
-69.94% | Details | |
| 3/3/2022 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | BioVie Inc. | BIVI | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2021 | BioVie Inc. | BIVI | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2021 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/19/2021 | BioLife Solutions | BLFS | New Coverage | Buy (N/A) |
41.61 (28.11) |
-32.44% | Details | |
| 10/19/2021 | CryoPort | CYRX | New Coverage | Buy (N/A) |
71.02 (15.49) |
-78.19% | Details | |
| 9/7/2021 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2021 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2021 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2021 | BioVie Inc. | BIVI | Maintain | Buy (N/A) |
|
Details |
